Taking into account the possibility of carcinogenic events associated with frequent genetic modifications in signalling pathways, we determined the amount, mechanism and co-occurrence of mutations in the c-MYC pathway across various tumour types and subtypes, as depicted in the heatmap (Figure 7C). The gene discussed is MYC; the disease is neoplasm.